Cannabis

Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD

Study aims to re-examine inhaled cannabis for treating PTSD, with Phase 2 study assessing high THC cannabis versus placebo for managing symptoms and pain in 360 veterans across U.S.

Sue Sisley, Shane Pennington

PS2023 Business Cannabis Policy and Advocacy Psychedelic Assisted Therapy Research and Science Social and Cultural

Lessons from the cannabis industry

Thirty-eight states and DC allow marijuana use, fueling a $13b industry. Psychedelic entrepreneurs seek lessons from cannabis market, noting similarities and differences for future growth.

Steve DeAngelo, Amanda Reiman, Troy Dayton

PS2023 Cannabis Policy and Advocacy Psychedelic Science Public Benefit Research and Science Social and Cultural

Challenges and opportunities of psychedelic policy reform in Jamaica

Senator interview delves into policy reform complexities in Jamaica, addressing cannabis legacy and future of psychedelic retreat centers. Discussion explores challenges, opportunities, and pathways to progressive drug policies for a

Adriana Kertzer, Sen Sherene Golding Campbell

PS2023 Cannabis Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Substance Use Disorder Veterans

Psychedelics, Exceptionalism, and Other Drugs

Psychedelics show promise in treating pain and addiction. Psychedelic policy reform can inspire bipartisan coalitions and benefit drug policy reform overall.

Ethan Nadelmann